Legrand India Elevates its Digital Transformation Journey with the Nividous Intelligent Automation Platform

Legrand has always focused on creating value for its stakeholders and excelling at all levels and identified its core accounts payable (AP) operations as one of the key actions for their enterprise-wide automation initiatives. The customer aimed to bring a more streamlined approach to improve its AP operations, involving multiple factories and entities across various… Continue reading Legrand India Elevates its Digital Transformation Journey with the Nividous Intelligent Automation Platform

Debevoise Welcomes Rick Sofield as Partner and Co-Head of the National Security Practice, Enhancing CFIUS and National Security Offerings

NEW YORK and WASHINGTON, Jan. 29, 2024 /PRNewswire/ — Debevoise & Plimpton LLP announces that Rick Sofield, a nationally recognized lawyer with 30 years of U.S. government and private sector national security experience, has joined the firm as partner in its Washington, DC office. Mr. Sofield will serve as Co-Head of the firm’s National Security practice… Continue reading Debevoise Welcomes Rick Sofield as Partner and Co-Head of the National Security Practice, Enhancing CFIUS and National Security Offerings

Dr. David Little and Dr. John Flucke Join CandidPro’s World-class Faculty

COLUMBUS, Ohio, Jan. 29, 2024 /PRNewswire/ — Candid, the company behind the revolutionary CandidPro clear aligner system, is opening 2024 with two more significant additions to its already impressive Candid Academy Faculty. David Little, DDS, and John Flucke, DDS, have agreed to bring their expertise and support to CandidPro. With these two industry powerhouses on board,… Continue reading Dr. David Little and Dr. John Flucke Join CandidPro’s World-class Faculty

Boost Payment Solutions Shares Business Momentum Highlighted by Over $12 Billion Processed and a 195% Year-Over-Year Increase in Transactions in 2023

Over 50 percent of the 2023 Fortune 100 companies have made or received payments through the Boost platform NEW YORK, Jan. 29, 2024 /PRNewswire/ — Boost Payment Solutions, a global leader in B2B payments, today shared some of the company’s key business highlights from 2023, including having processed a company-record single largest commercial card payment in 2023… Continue reading Boost Payment Solutions Shares Business Momentum Highlighted by Over $12 Billion Processed and a 195% Year-Over-Year Increase in Transactions in 2023

Survey Reveals That US C-Suite Executives Are Three Times More Likely to Choose India Over China for Their Supply Chain Needs

OnePoll survey reveals that 61% of US executives said they would consider sourcing from India if they knew India had the same materials as China WASHINGTON, Jan. 29, 2024 /PRNewswire/ — India Index (www.indiaindex.com) today announced that an independent third party survey of 500 US C-Suite executives by OnePoll revealed striking findings on US leaders’… Continue reading Survey Reveals That US C-Suite Executives Are Three Times More Likely to Choose India Over China for Their Supply Chain Needs

Leaf Home Names Chief Financial Officer; Former Rent the Runway CFO Scarlett O’Sullivan Joins Home Improvement Company

HUDSON, Ohio, Jan. 29, 2024 /PRNewswire/ — Leaf Home™, a leading technology-enabled direct-to-consumer provider of home improvement products and solutions, has named Scarlett O’Sullivan as the company’s Chief Financial Officer (CFO). In this role, O’Sullivan will play a key part in scaling the business while also preparing it for the next stage of growth. Prior to… Continue reading Leaf Home Names Chief Financial Officer; Former Rent the Runway CFO Scarlett O’Sullivan Joins Home Improvement Company

Legal-Bay Announces New Website Page for Medical and Doctor Personal Injury Receivables Funding Programs

Legal Funding Firm launches new site dedicated to funding requests for doctors, medical providers, and surgical facilities that are short on cash-flow while they wait for personal injury settlement payments on their account receivables. NEWARK, N.J., Jan. 29, 2024 /PRNewswire/ — Legal-Bay LLC, The Lawsuit Pre-Settlement Funding Company, announced today that they’ve launched a new page dedicated… Continue reading Legal-Bay Announces New Website Page for Medical and Doctor Personal Injury Receivables Funding Programs

John R. Wood Properties’ 2023 Performance Leads Collier, Lee County Brokerages

Region’s oldest major real estate brokerage achieves highest sales volume for third consecutive year NAPLES, Fla., Jan. 29, 2024 /PRNewswire/ — John R. Wood Christie’s International Real Estate today announced 2023 sales volume of $4.5 billion, more than $1.4 billion ahead of its nearest competitor.* The multibillion-dollar company, which joined the Christie’s International Real Estate… Continue reading John R. Wood Properties’ 2023 Performance Leads Collier, Lee County Brokerages

Hairitage Expands Retail Footprint, Launches at Kroger, CVS and HEB Nationwide

“We’ve been listening to what the Hairitage community wants, and I’m so excited to expand into new retailers, making Hairitage more accessible to all families,” said Mindy McKnight, Hairitage Founder and CEO. “As one of the top hair care brands at Walmart, offered in the company of legacy brands that have been around for 15+… Continue reading Hairitage Expands Retail Footprint, Launches at Kroger, CVS and HEB Nationwide

Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company’s Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

SHANGHAI and ROSELAND, N.J., Jan. 29, 2024 /PRNewswire/ — Oricell Therapeutics (Oricell), a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for OriCAR-017 for patients with relapsed/refractory multiple myeloma (R/R MM). OriCAR-017 is a chimeric antigen receptor (CAR) T cell therapy… Continue reading Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company’s Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.